PCA(P)(2026)21 - Community Pharmacy Funding 2026/27

This information was correct at the time of publication. Policy and guidance can change, so please check our latest news for the current position. For anything else, please contact enquiries@cps.scot

Summary

1. This circular sets out further detail to community pharmacy contractors and NHS Boards on the funding arrangements for 2026/27, including the breakdown of funding into separate pools.

Detail

2. PCA(P)(2026) 17 issued on 25 September 2026 sets out the high level details of the community pharmacy package for 2026/27. These are:

  • A. The remuneration Global Sum will be reset for 2026/27 at £250.483m, an increase of 3.5% on the previous year and sets the baseline figure for 2027/28.

  • B. The non-Global Sum shall roll forward at its current level set at £1.3m.

  • C. The continued mapping of funding from Part 7 (generic) Drug Tariff as guaranteed income will increase by £10m to £110m for the financial year 2026/27. Mapped guaranteed income is not subject to an annual uplift. The increase in mapped monies will be delivered by an equivalent reduction in drug tariff prices. This additional quantum will be allocated to the dispensing pool.

3. Taking these points A to C above, the total guaranteed funding to be delivered in 2026/27 is £361.78m.

4. The current level of Guaranteed Minimum Income has also increased by £10m to £130m. The delivery of the Guaranteed Minimum Income will be closely monitored on a monthly basis and action taken on a quarterly basis during the financial year via a cashflow protection mechanism, if required.

5. Repayment of the 2023 advance will commence when margin exceeds £150m. A working group involving Scottish Government officials, Community Pharmacy Scotland, Health Boards representatives and Public Services Delivery Scotland (PSDS) will shortly be convened to consider the detail of this repayment. A further circular will issue to set out the conclusions of this group in due course.

6. Margin sharing will also commence on a 50:50 basis between NHS Boards and community pharmacy owners when margin exceeds £160m.

7. Ongoing monitoring of points 4, 5 and 6 will be undertaken by the Scottish Government.

8. Full details of the breakdown of funding to the different pools is provided below.

Consultation

9. CPS, Health Board representatives and PSDS have been consulted on the contents of this circular.

Action

10. NHS Boards are asked to copy this circular to all community pharmacy contractors on their pharmaceutical lists, Health and Social Care Partnerships and the Area Pharmaceutical Committee.

Yours sincerely,

Alison Strath
Chief Pharmaceutical Officer / Deputy Director Pharmacy, Medicines and Therapeutics Division

Drug Tariff provisions with respect to community pharmacy remuneration with effect for dispensing period from April 2026

Dispensing Pool Payment – standard arrangements for contractors with established dispensing histories – annualised pool £195.444m

From 1 April 2026, all contractors on the pharmaceutical list on the first day of the dispensing month will be eligible to receive a Dispensing Pool Payment. This will be calculated as a discrete payment for each contractor.

For dispensing months from April 2026 onwards it will be calculated as a share of a total monthly dispensing pool of £16.29m.

On 30 November 2026, eligible contractors will receive a one-off payment as a proportionate share of a £9.282m backdated payment pot to rebalance April to September 2026 dispensings in line with the year's Dispensing Pool annualised budget. Subsequent months and quarters will be paid as a proportionate share of the £195.444m pot.

In recognition of the activity associated with complex dispensings and to avoid the need for a separate payment, the aggregate dispensing pool and each contractor's share will compromise discrete dispensing plus instalments, with each instalment weighted on a par with a dispensing.

Dispensing Pool Payment – arrangements for contractors recently added to the pharmaceutical list and/or with incomplete dispensing history, or whose dispensing pool payment would otherwise fall below the minimum target

A minimum monthly payment of £750 will apply for dispensing months April 2026 onwards to eligible contractors who were not on the list, or where no previous contractor was on the list for the applicable prior reference period used when calculating the dispensing pool payments. The minimum payment will remain in place until the contractor has three consecutive months of dispensing activity to be used to determine the dispensing pool payment.

If a contractor recently added to the list considers that the £750 payment does not fairly reflect their share of the overall dispensing activity in the first three months of operation, they may make a request to Primary & Community Care (PaCC) in PSDS (nss.psdhelp@nhs.scot) within nine months of the dispensing months concerned for a retrospective adjustment calculation to be completed. This will establish if an adjustment, calculated by reference to the previous quarter's dispensing pool, would be appropriate.

If the total amount due is less than the £750 already paid, no further action will be taken. If the amount due exceeds £750 an adjustment will be made as soon as practical for the months concerned and if necessary, as a retrospective payment. This provision is back dated to apply for payments to dispensing month April 2026 onwards.

Medicines: Care and Review (M:CR) Service Capitation Payment – annualised pool £36.049m

Contractors, on the list on the first day of the dispensing month and contracted with their NHS Board to provide M:CR, will receive a share from this pool in proportion to the number of patients registered for M:CR and assigned a priority care plan in the patient's Pharmacy Care Record on the last day of the month concerned.

A rebasing exercise of the M:CR capitation pool has taken place. Going forward, this will be measured against volume as opposed to GIC value as a more accurate reflection of contractor workload.

Establishment Payment – annualised pool £37.740m

A single flat rate payment of £2,500 will be made to contractors on the pharmaceutical list on the first day of each dispensing month.

For part time ESPs, the Establishment Payment will be made as a proportion of the single flat rate payment of £2,500 as set out below:

  • Over 5 but less than 10 hours open: 60% of single flat rate payment

  • Over 10 but less than 15 hours open: 75%

  • Over 15 but less than 20 hours open: 85%

  • Over 20 but less than 25 hours open: 90%

  • Over 25 but less than 30 hours open: 95%

  • Over 30 hours open: 100%

Unscheduled Care – annualised pool £4.38m

The annualised pool of £4.38million recognises the supply of medicines against the unscheduled care Patient Group Direction (PGD). From 1 April 2026 all contractors on the pharmaceutical list on the first day of the month will be eligible to receive a base payment of £100 and an associated unscheduled care activity payment derived from a fixed funding pot in the region of £2.88m.

NHS Pharmacy First Scotland Service – annualised pool £35.8m

As outlined in Circular PCA(P) (2021) 20, contractors on the board's pharmaceutical list on the first day of the month will receive a base payment of £1,000. From 1 April 2026, and for each month thereafter, all contractors will receive the base payment of £1,000 and an activity payment from the activity payment pot of £1.725m where their activity level is above a specified minimum of 100 interventions per month – with activity being recorded on PMR systems as Advice, Referral or Treatment.

A review of the NHS Pharmacy First and Pharmacy First Plus remuneration model is planned and any change will be communicated via a further circular.

Should a new contractor take over responsibility for an existing community pharmacy mid-month, they can gain access to the activity pot should they exceed the minimum activity threshold.

Community Pharmacy Independent Prescribing (NHS Pharmacy First Plus) – annualised pool £23.529m

Circular PCA(P) (2020) 16 set out the intention to introduce a combined National Foundation Programme and Independent Prescriber (IP) Career Pathway for community pharmacists. It also described the terms of a pharmacist Independent Prescriber led common clinical conditions service which has become known as NHS Pharmacy First plus.

A monthly fee of £3,000 will be made to the contractor named on a Board's pharmaceutical list at the first day of that month for each full month the service is made available in the community pharmacy. Contractors should complete the form at Annex A of Circular PCA(P) (2020) 16. The service should only be made available once the prescribing IP is able to prescribe as an IP on the NHS – this will require a prescriber code and, until such times as a prescribing system is developed to support this service electronically, a prescription pad. The service provider will complete a self-declaration form to indicate that a pharmacist IP is available to provide this service for at least a minimum of 25 hours per week, for a minimum of 45 weeks of a rolling year from the date the service starts.

Circular PCA(P) (2025) 24 sets out the current remuneration model for Pharmacy First Plus in detail. These arrangements will remain in place, with contractors delivering the service as specified receiving an activity payment from the established monthly pot for IP prescribing activity, agreed at £0.5m. There is no minimum activity threshold set to access the NHS PFS Plus activity payment pot.

A review of the implementation of this arrangement is planned. As noted previously, any change will be communicated via a further circular.

Quality and Service Development (QSD) Payment – annualised pool £4.246m

For the dispensing months April 2026 – March 2027, the aggregate monthly amount available for the calculation of the target Quality and Service Development payments to contractors is £0.354m.

Quality Improvement

Contractors on the pharmaceutical list from 1 April 2026 will be entitled to a fixed fee of £280, paid monthly. Contractors should note that activities from April 2026 onwards will support the implementation and training requirements for the enhancement of NHS Pharmacy First Scotland, other contractual services and Public Health Services, and timely completion of the PSDS Community Pharmacy Workforce Survey in 2026.

Gluten Free Food Service – annualised pool £2.0m

All contractors who are on the list on the first day of the dispensing month and who have accepted their Health Board's invitation to offer Gluten Free Foods as an additional pharmaceutical service will receive a monthly fixed payment of £100. All contractors in the dispensing month concerned shall receive an activity payment from an annual fixed funding pot of around £500k.

All contractors providing GFFS must ensure that patients' full and accurate CHI numbers are provided.

Service Efficiency Payment – annualised pool £5.762m

In order to continue the drive to adopt a digital first approach to claiming, electronic claims must be the default approach for all reimbursement claims where possible. Arrangements for the monthly Service Efficiency Payment will continue as an absolute eClaim target that will measure all AMS claims, including care home, instalment and stoma claims. The target rate of claims will continue at 80%.

All new contractors on the pharmaceutical list at or since 1 April 2026 will receive the monthly Service Efficiency Payment of £150. The payment will be calculated as:

SE% = Total eClaims / Total Possible eClaims (inclusive of care home, instalment and stoma claims)

At or above the threshold a contractor will receive a payment at the rate of each contractors own Service Efficiency Payment. Below the threshold, contractors will not be eligible for any payment, except in the following circumstances:

A contractor who would not otherwise receive a payment for a particular month may request the Health Board consider failure to achieve the 80% threshold is exceptional and out with the contractor's control and authorise a special payment. If the application is made, and the Health Board determines failure to achieve the target threshold is out with the contractor's control, a payment may be authorised at the Health Board's discretion.

Patient Services element of Public Health Service (PHS), Smoking Cessation, Emergency Hormonal Contraception and Bridging Contraception (Sexual Health) – total annualised pool £4.250m

All contractors who have arrangements in place with Health Boards for the provision of PHS will receive payments in respect of the dispensing months April 2026 onwards for the following services:

PHS Smoking Cessation

A contractor will be remunerated for the submission of MDS information at each of the three quit attempt milestones and rates are noted below. Milestones are intended to help improve the level of service provided to patients looking to quit smoking and the monitoring of that through the HEAT target process.

  • Event A – Submission of the MDS information with confirmed quit date (normally first return appointment)

    • MDS submission: To be electronically submitted once the quit date is confirmed with the client. This will inform the basis of the timelines for the four week and twelve week date follow up.

    • Remuneration basis: A count will be made on the central smoking cessation database of patients for MDS submission for new quit attempts that meet the validation requirements that have not been remunerated.

  • Event B – Four week post quit date

    • MDS submission: To be electronically submitted immediately after the four week post quit date and not later than six weeks from the confirmed quit date.

    • Remuneration basis: A count will be made on the central smoking cessation database of patients for MDS submission for the four week stage that meet the validation requirements that have not been remunerated.

  • Event C – Twelve week post quit date

    • MDS submission: To be electronically submitted immediately after the twelve week post quit data and not later than sixteen weeks from the confirmed quit date.

    • Remuneration basis: A count will be made on the central smoking cessation database of patients for MDS submission for the twelve weeks stage that meets the validation requirements that have not been remunerated.

The patient count will be made at the end of the calendar month. Capitation payment in respect of patients at each of the following event stages:

  • Event A: £30

  • Event B: £15

  • Event C: £35

An updated Patient Group Directive was issued on 10 April 2025 for the use of varenicline to replace Champix©. Further details can be found at PCA(P) (2025) 06.

PHS Emergency Hormonal Contraception (Sexual Health)

All contractors who have arrangements with NHS Boards for the provision of the Emergency Hormonal Contraception will receive a capitation payment of £30 per consultation reported by a contractor.

PHS Bridging Contraception (Sexual Health)

All contractors who have arrangements with NHS Boards for the provision of Bridging Hormonal Contraception will receive a capitation payment of £30 per consultation reported by a contractor. PCA(P) (2021) 12 provides details on the Bridging Contraception service.

Pharmaceutical Needs Weighting Payment – annualised pool £3.845m

From April 2026, all contractors on the list at the start of the dispensing month and in receipt of a Dispensing Pool Payment will be eligible for the period April 2026 – March 2027 for a Pharmaceutical Needs Weighting Payment. This acknowledges the additional pharmaceutical needs arising from age and deprivation characteristics of the post code of presenting patients. For dispensing months April 2026 onwards it will be calculated from a monthly pool of £0.320m.

For each contractor, the following has been identified:

  • Proportion of dispensing patients aged 60 years or over

  • The percentage of dispensing patients with postcodes in the two most deprived quintiles according to the Scottish Index of Multiple Deprivation (SIMD)

Two indices will be calculated in accordance with the following and those two discrete indices are averaged to produce a combined index which is the weighting to be applied.

Age Index

  • 75% or more of patients under 60 years: 1.0

  • 65% - 75% of patients under 60 years: 1.2

  • 65% - 75% of patients under 60 years, with more aged 75+ than between 60 - 74: 1.3

  • 55% - 65% of patients under 60 years: 1.4

  • 55% - 65% of patients under 60 years, with more aged 75+ than between 60 - 74: 1.5

  • 45% - 55% of patients under 60 years: 1.6

  • 45% - 55% of patients under 60 years, with more aged 75+ than between 60 - 74: 1.7

  • 35% - 45% of patients under 60 years: 1.8

  • Less than 35% of patients under 60 years: 2.0

SIMD Index

  • 40% or less of patients with postcodes in the two most deprived quintiles: 1.0

  • 40% - 60% of patients with postcodes in the most deprived quintiles: 1.2

  • 40% - 60% of patients with postcodes in the most deprived quintiles and more in the most deprived quintiles: 1.2

  • 60% - 80% of patients with postcodes in the most deprived quintiles: 1.4

  • 60% - 80% of patients with postcodes in the most deprived quintiles and more in the most deprived quintiles: 1.5

  • 80% - 90% of patients with postcodes in the most deprived quintiles: 1.6

  • 80% - 90% of patients with postcodes in most deprived quintiles and more in the most deprived quintiles: 1.7

  • More than 90% of patients with postcodes in the most deprived quintiles: 1.8

  • More than 90% of patients with postcodes in the most deprived quintiles and more in the most deprived quintiles: 2.0

The combined index will be applied to the monthly pool, derived from the total transitional payments available for redistribution to determine the Pharmaceutical Needs Weighting Payment for each contractor. Contractors added to the list between 1 April 2026 and 31 March 2027 inclusive and/or without any dispensing history in the reference period will receive a proxy monthly Pharmaceutical Needs Weighting Payment calculated using a combined index of 1.0.

Stock Order on Cost – annualised pool £1.413m

The on cost allowance for items (except pneumococcal vaccines) ordered by general medical practitioners on Form GP10A is 17.5% of the net ingredient cost, calculated in accordance with paragraph 16 of Part 1 of the Drug Tariff.

Guaranteed Minimum Target Income for an Essential Small Pharmacy (ESP) – annualised pool £0.124m

The total Establishment Payment plus Dispensing Pool plus Pharmaceutical Needs Weighting Payment made to an ESP each month is £4,976 for full time contractors.

An equivalent guarantee for part time contractors is calculated as follows:

  • Over 5 but less than 10 hours open: 60% of single flat rate payment

  • Over 10 but less than 15 hours open: 75%

  • Over 15 but less than 20 hours open: 85%

  • Over 20 but less than 25 hours open: 90%

  • Over 25 but less than 30 hours open: 95%

  • Over 30 hours open: 100%

The total of Establishment Payment plus Dispensing Pool plus Pharmaceutical Needs Weighting Payment to be made to an ESP each month will be calculated as for all other contractors and if that aggregate is less than the level of the guaranteed minimum payment at a top up – the Essential Small Pharmacy Allowance – equivalent to the shortfall will be paid for the months concerned. Eligibility for the ESP requires a contractor to be included on the register of essential small pharmacies held by their host NHS Board. Contractors taking over an existing ESP must have their continued inclusion in the ESP register approved by the Health Board.

Measured and Fitted Fees – annualised pool £0.147m

For dispensings from April 2026 onwards, a measured and fitted fee of £25 is payable in respect of hosiery and all lymphedema garments which have been 'measured and fitted' if the prescription concerned is submitted for reimbursement appropriately endorsed 'measured and fitted'. The measured and fitted fee payable in respect of trusses is £250. This includes made to measure products.

Post Registration Programme for Pharmacists (Scotland) (formerly the Post Registration National Foundation for Newly Qualified Pharmacists) – annualised pool £2.0m

To support the Post Registration Programme for pharmacists, a monthly fee of £1,000 (£12,000 per annum) will be made available to a contractor named on the pharmaceutical list on the first of each month who supports the Post Registration Programme for Pharmacists (Scotland). Payments will be made to contractors monthly for the 12 month period or subject to a change in contractors' status of participation. Contractors should note the change from a 24 month to 12 month programme.

Staff Training – annualised pool £2.751m

The budget annualised pool is £2.751m in 2026/27. A monthly payment will be made of £180 per month per contractor.

All contractors on the pharmaceutical list from the first day of month will be eligible for the payment.

Independent Prescribing Legacy Workforce – annualised pool £1m

Scottish Government has agreed to an annualised pool of £1m to support the role of Pharmacist Independent Prescribers in community pharmacies.

Other Payments

All other payments to community pharmacy contractors which are not set centrally under the Pharmaceutical Services arrangements e.g. locally set fees for methadone dispensing etc. and centrally set fees for non-Pharmaceutical Services such as stoma appliance dispensing services will continue unchanged unless otherwise notified.

Arrangements for contractors added to the list from 1 April 2026 onwards

Where a contractor is added to the list on 1 April 2026, PSDS will invite them to confirm whether they are a brand new contractor or whether they are taking over from an existing contractor already on the Pharmaceutical List and in the same location. Those contractors who are taking over from an existing contractor will for the purpose of calculation payments to be made, be assumed to inherit the characteristics, dispensing history, and stabilisation arrangements etc. of the predecessor contractor.

Calculation of monthly advance payments

The method of calculation of advance payments to community pharmacy contractors in respect of centrally set remuneration and reimbursement for dispensing months April 2026 onwards is as follows:

The advance payment for dispensing months February – March inclusive is calculated as 100% of the 12 months mean monthly payment made to each contractor or its predecessor over the immediately preceding 12-month period for which calculated actual gross payments for the remuneration payments and reimbursements are available, at the time the advance payment is calculated.

Where a contractor or their predecessor has a history of less than 12 months actual payments at the time the advance is calculated, it will be calculated as 100% of the mean of the number of actual months for which data is available.

For brand new contractors the advance payment will be calculated as follows:

  • Month one advance = (no. of days open /28/29/30/31) x £18,000

  • For contractors who opened on the first of the month, their month two and subsequent advances will be calculated as the % applied to advance payments for all contractors as above for that month of the mean of the number of actual months which data is available.

  • For contractors who opened during the month, their month two advance will equal: (no. of days /28/29/30/31) x £18,000; month three and subsequent advances until a 12 month history is available will be calculated as the % applied to advance payments for all contractors as above for that month of the mean of the number of actual months for which data is available.

Contractors in exceptional circumstances

Where a contractor has been subject to specific exceptional circumstances resulting in an interruption or delay in start of business operation i.e. due to fire, flood or another exceptional circumstance which in the Board's opinion was out with the contractor's control and as a result the premises were rendered unfit for trade, the Board may, at its discretion, grant an application from the contractor for a payment or proportion of a payment stated in the Drug Tariff and which would otherwise have been paid, provided the Board is satisfied that it would be reasonable to do so. Nothing in this paragraph removes the need for contractors to conduct their business with normal commercial diligence and to be appropriately insured.

Funding pools 2026/27 – summary

Each line shows the pool, its purpose, the 2026/27 amount and the change from 2025/26.

Core funding

  • Dispensing Pool (General Funding): £195,444,000 – change from 2025/26: £18,565,000

  • Establishment Payment (General Funding): £37,740,000 – change from 2025/26: £0

  • Stock Order on Cost (On cost allowance): £1,413,000 – change from 2025/26: £0

Provision of services

  • Pharmacy First (Provision of Pharmacy First Service): £35,800,000 – change from 2025/26: £0

  • Pharmacy First Plus (Independent Prescribing): £23,529,000 – change from 2025/26: £0

  • Medicines Care and Review (Care for people with long term conditions): £36,049,000 – change from 2025/26: £0

  • Unscheduled Care (Supply of medicines on unscheduled care PGD): £4,380,000 – change from 2025/26: £300,000

  • Gluten Free Foods (Provision of Gluten Free Food): £2,000,000 – change from 2025/26: £0

  • Public Health Services (Smoking cessation; contraception): £4,250,000 – change from 2025/26: £0

  • Measured and Fitted Fees (Provision of hosiery and lymphedema garments): £147,000 – change from 2025/26: £0

Staff training

  • Quality and Service Development (Support for training): £4,246,000 – change from 2025/26: £0

  • Post Registration Programme for Pharmacists (Support for newly qualified pharmacies): £2,000,000 – change from 2025/26: £0

  • Staff Training (Staff Training): £2,751,000 – change from 2025/26: £0

  • IP Legacy Workforce (Support for 'legacy' workforce): £1,000,000 – change from 2025/26: £0

Socio-economic adjustments

  • Pharmaceutical Needs Weighting Payment (Deprivation adjustment): £3,845,000 – change from 2025/26: £0

  • GMI for Essential Small Pharmacy (Top up of payments to deliver target income): £124,000 – change from 2025/26: £0

Digital

  • Service Efficiency Payment (Encouragement of electronic claims): £5,762,000 – change from 2025/26: £0

Non Global Sum

  • Non Global Sum: £1,300,000 – change from 2025/26: £0

Total: £361,780,000 – change from 2025/26: £18,865,000


Frequently Asked Questions (FAQs)

Scottish Government

The devolved government for Scotland has a range of responsibilities that include: the economy, education, health, justice, rural affairs, housing, etc...

https://www.gov.scot/
Next
Next

Business Support Assistant - Edinburgh